BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Obesity
,
Adipose tissue
,
Nosology
,
Rapamycin
,
rs2476601
,
KLK3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phosphohistone- H3
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for phosphohistone- H3
Explore Curated Studies Results
Literature
Most Relevant Literature
The usefulness of immunohistochemistry for phosphohistone H3 as a prognostic factor in myxoid liposa…
Analysis of Tumor Proliferation Markers in Early-Stage Luminal Breast Cancer: A Comprehensive Study …
The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is Th…
Improving precise counting of mitotic cells in mantle cell lymphoma using phosphohistone H3 (PHH3) a…
The value of Phosphohistone H3 as a cell proliferation marker in oral squamous cell carcinoma. A com…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors
Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors
Neoadjuvant and Adjuvant Checkpoint Blockade
Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or R…
A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ